| __timestamp | ImmunityBio, Inc. | Ionis Pharmaceuticals, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 641000 | 214161000 |
| Thursday, January 1, 2015 | 236000 | 283703000 |
| Friday, January 1, 2016 | 44000 | 346620000 |
| Sunday, January 1, 2017 | 45000 | 507666000 |
| Monday, January 1, 2018 | 47000 | 599674000 |
| Tuesday, January 1, 2019 | 2202000 | 1123000000 |
| Wednesday, January 1, 2020 | 605000 | 729000000 |
| Friday, January 1, 2021 | 934000 | 810000000 |
| Saturday, January 1, 2022 | 240000 | 587000000 |
| Sunday, January 1, 2023 | 622000 | 787647000 |
| Monday, January 1, 2024 | 705138000 |
Cracking the code
In the competitive world of biotechnology, Ionis Pharmaceuticals, Inc. and ImmunityBio, Inc. have been vying for revenue supremacy over the past decade. From 2014 to 2023, Ionis Pharmaceuticals has consistently outperformed ImmunityBio, showcasing a robust revenue growth trajectory. In 2019, Ionis reached a peak with revenues soaring to over $1.1 billion, a staggering 50 times more than ImmunityBio's highest revenue year in the same period.
ImmunityBio, while trailing, has shown resilience with a notable revenue spike in 2019, reaching $2.2 million, a significant leap from its previous years. Despite this, Ionis's revenue in 2023 was approximately 1,266% higher than ImmunityBio's, highlighting its dominant market position.
This data underscores the dynamic nature of the biotech industry, where innovation and strategic positioning can lead to substantial financial outcomes.
Who Generates More Revenue? Merck & Co., Inc. or Ionis Pharmaceuticals, Inc.
Who Generates More Revenue? Regeneron Pharmaceuticals, Inc. or Ionis Pharmaceuticals, Inc.
United Therapeutics Corporation and ImmunityBio, Inc.: A Comprehensive Revenue Analysis
Incyte Corporation vs Ionis Pharmaceuticals, Inc.: Annual Revenue Growth Compared
Incyte Corporation and ImmunityBio, Inc.: A Comprehensive Revenue Analysis
Annual Revenue Comparison: Catalent, Inc. vs ImmunityBio, Inc.
Breaking Down Revenue Trends: Ionis Pharmaceuticals, Inc. vs Vericel Corporation
Ionis Pharmaceuticals, Inc. and ImmunityBio, Inc.: SG&A Spending Patterns Compared
Who Generates More Revenue? TG Therapeutics, Inc. or ImmunityBio, Inc.
Revenue Insights: ImmunityBio, Inc. and Amphastar Pharmaceuticals, Inc. Performance Compared
Comparing Revenue Performance: ImmunityBio, Inc. or Novavax, Inc.?
Revenue Insights: ImmunityBio, Inc. and MiMedx Group, Inc. Performance Compared